EPSGrowth1 Medtronic (MDT) Stock Analysis: Why EPS Stayed Flat Despite 10-Year-High Revenue Growth Medtronic (NYSE: MDT) closed fiscal 2026 with revenue of $36.36 billion, up +8.4% as reported and +5.8% organic, the fastest annual growth the company has posted in a decade. This MDT stock analysis works through what produced that growth, why non-GAAP earnings per share still sits where it did four years ago, what the MiniMed spin-off changes, how the shares are priced against Boston Scientific.. 2026. 8. 31. 이전 1 다음
